TABLE 5.
Antimicrobial | No. of isolatesb |
EAc (no. [%]) | CAd (no. [%]) | VMEe (no. [%]) | MEf (no. [%]) | mEg (no. [%]) | |||
---|---|---|---|---|---|---|---|---|---|
Total | R | I | S | ||||||
Ampicillin | 78 | 36 | 0 | 42 | 78 (100) | 78 (100) | 0 (0) | 0 (0) | 0 (0) |
Ciprofloxacin | 78 | 48 | 6 | 24 | 78 (100) | 73 (93.6) | 0 (0) | 0 (0) | 5 (6.4) |
Daptomycin | 32h | 6 | 0 | 26 | 31 (96.9) | 30 (93.8) | 2 (33.3) | 0 (0) | 0 (0) |
Erythromycin | 78 | 58 | 15 | 5 | 78 (100) | 75 (96.2) | 0 (0) | 0 (0) | 3 (3.8) |
Gentamicin (high level) | 78 | 16 | 0 | 62 | 78 (100) | 77 (98.7) | 0 (0) | 1 (1.6) | 0 (0) |
Linezolid | 78 | 5 | 4 | 69 | 78 (100) | 76 (97.4) | 0 (0) | 0 (0) | 2 (2.6) |
Nitrofurantoin | 78 | 19 | 17 | 42 | 76 (97.4) | 71 (91) | 0 (0) | 1 (2.4) | 6 (7.7) |
Quinupristin-dalfopristin | 73 | 25 | 5 | 43 | 73 (100) | 73 (100) | 0 (0) | 0 (0) | 0 (0) |
Streptomycin (high level) | 78 | 37 | 0 | 41 | 78 (100) | 78 (100) | 0 (0) | 0 (0) | 0 (0) |
Tigecycline | 78 | 0 | 0 | 78 | 78 (100) | 78 (100) | 0 (0) | 0 (0) | 0 (0) |
Vancomycin | 73 | 35 | 0 | 38 | 73 (100) | 73 (100) | 0 (0) | 0 (0) | 0 (0) |
Total | (99.5) | (97.3) | 2 | 2 | 16 |
Results calculated following resolution of discrepancies after repeat testing.
R, resistant; I, intermediate; S, susceptible.
EA, essential agreement (within ±1 doubling dilution).
CA, categorical agreement.
VME, very major error.
ME, major error.
mE, minor error.
E. faecalis only.